Raub Brock Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Raub Brock Capital Management's LLY Position: Q2 2026 in Review
Raub Brock Capital Management reduced its Eli Lilly (LLY) stake by 26% in Q2 2026, selling an estimated $4.97M and leaving 13,706 shares worth $16.4M. The position accounts for 4.53% of the portfolio, ranked #3.
Raub Brock Capital Management first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. The position peaked at $24M in Q3 2023. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Raub Brock Capital Management held 13,706 shares of Eli Lilly worth $16.4M as of Q2 2026.
- Raub Brock Capital Management sold 4,866 Eli Lilly shares in Q2 2026, an estimated $4.97M.
- Eli Lilly made up 4.53% of Raub Brock Capital Management's portfolio in Q2 2026, its #3 holding.
- Raub Brock Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- Raub Brock Capital Management's Eli Lilly position peaked at $24M in Q3 2023.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Raub Brock Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.